Autoimmune Inner Ear Disease: The Current State of Knowledge.
6 affiliations
- 1Center of Hearing and Speech, 7 Mokra Street, 05-830 Kajetany, Poland.
- 2Faculty of Health Sciences, University of Applied Sciences, 2 Popieluszko Street, 62-510 Konin, Poland.
- 3Department of Teleaudiology and Screening, World Hearing Center, Institute of Physiology and Pathology of Hearing, 10 Mochnackiego Street, 02-042 Warsaw, Poland.
- 4Institute of Sensory Organs, 1 Mokra Street, Kajetany, 05-830 Nadarzyn, Poland.
- 5Heart Failure and Cardiac Rehabilitation Department, Faculty of Dental Medicine, Medical University of Warsaw, 8 Kondratowicza Street, 03-242 Warsaw, Poland.
- 6Institute of Physiology and Pathology of Hearing, 10 Mochnackiego Street, 02-042 Warsaw, Poland.
Abstract
Background/Objectives: An increasing number of cases of sensorineural hearing loss are caused by autoimmune inflammatory reactions within the cochlea, which can either be limited to the inner ear or associated with other systemic autoimmune reactions. The objective of this work was to conduct a narrative review of the worldwide literature from the past five years, to summarize the current state of knowledge on autoimmune hearing loss, and to understand its pathology and its treatment strategies. As a narrative review, our publication aimed to describe the most interesting and up-to-date case reports that add to our knowledge of autoimmune inner ear conditions. Methods: We searched the Scopus, Web of Science, and PubMed databases using the key phrases "autoimmune inner ear disease", "autoimmune sensorineural hearing loss", and "sudden sensorineural hearing loss". The selection covered papers published within the past five years. Results: Based on the selection criteria, we identified 122 relevant articles. Further analysis and limitation to the main scope of the review led to the final selection of 48 papers, which formed the basis for this review. Conclusions: Autoimmune hearing loss appears to be an increasing clinical problem. The underlying pathology can be limited to the ear; however, it may also occur during the course of other autoimmune processes with multisymptomatic manifestations in different systems and organs. The underlying pathology is an immune-mediated inflammatory response to antigens, including self-antigens located in a patient's body tissues. This pathology leads to various dysfunctions. Diagnosis is challenging, as there are no specific diagnostic criteria. Inflammatory markers are usually elevated; however, they are not specific enough to determine a final diagnosis. Treatment strategies differ, depending on the symptoms; however, immunosuppressive drugs, mainly corticosteroids (systemic or trans tympanic), appear to be a treatment of choice.
Related
- Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training
- The Impact of Frequent Alarm Exposure on Intensive Care Nurses—A Mapping of the Current State of Knowledge
- The Current State of Primary Clinical Spine Disease Research in Sub-Saharan Africa — A Scoping Review
- Knowledge, Attitudes, and Practices Regarding Autoimmune Thyroiditis Among Patients in Jilin: A Cross-Sectional Endocrinology Department Study.
- Sex and disease differences in patients’ diagnostic experiences in autoimmune diseases: an international cross-sectional study
BibTeX
@article{myszel2026autoimmune,
title = {{Autoimmune Inner Ear Disease: The Current State of Knowledge.}},
author = {Karol Myszel and Piotr Henryk Skarżyński and Tomasz Michalak},
journal = {Audiology research},
year = {2026},
month = oct,
doi = {10.3390/audiolres16050159},
url = {https://europepmc.org/article/MED/42930357},
note = {CC BY},
}
RIS
TY - JOUR
TI - Autoimmune Inner Ear Disease: The Current State of Knowledge.
AU - Karol Myszel
AU - Piotr Henryk Skarżyński
AU - Tomasz Michalak
PY - 2026
DA - 2026/10/18
JO - Audiology research
DO - 10.3390/audiolres16050159
UR - https://europepmc.org/article/MED/42930357
AB - Background/Objectives: An increasing number of cases of sensorineural hearing loss are caused by autoimmune inflammatory reactions within the cochlea, which can either be limited to the inner ear or associated with other systemic autoimmune reactions. The objective of this work was to conduct a narrative review of the worldwide literature from the past five years, to summarize the current state of knowledge on autoimmune hearing loss, and to understand its pathology and its treatment strategies. As a narrative review, our publication aimed to describe the most interesting and up-to-date case reports that add to our knowledge of autoimmune inner ear conditions. Methods: We searched the Scopus, Web of Science, and PubMed databases using the key phrases "autoimmune inner ear disease", "autoimmune sensorineural hearing loss", and "sudden sensorineural hearing loss". The selection covered papers published within the past five years. Results: Based on the selection criteria, we identified 122 relevant articles. Further analysis and limitation to the main scope of the review led to the final selection of 48 papers, which formed the basis for this review. Conclusions: Autoimmune hearing loss appears to be an increasing clinical problem. The underlying pathology can be limited to the ear; however, it may also occur during the course of other autoimmune processes with multisymptomatic manifestations in different systems and organs. The underlying pathology is an immune-mediated inflammatory response to antigens, including self-antigens located in a patient's body tissues. This pathology leads to various dysfunctions. Diagnosis is challenging, as there are no specific diagnostic criteria. Inflammatory markers are usually elevated; however, they are not specific enough to determine a final diagnosis. Treatment strategies differ, depending on the symptoms; however, immunosuppressive drugs, mainly corticosteroids (systemic or trans tympanic), appear to be a treatment of choice.
SN - 2039-4330
SN - 2039-4349
ER -